| 000 | 01231 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250515152017.0 | ||
| 264 | 0 | _c20090116 | |
| 008 | 200901s 0 0 eng d | ||
| 022 | _a1871-5303 | ||
| 024 | 7 |
_a10.2174/187153008786848330 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMwaikambo, B R | |
| 245 | 0 | 0 |
_aEmerging roles for the CD36 scavenger receptor as a potential therapeutic target for corneal neovascularization. _h[electronic resource] |
| 260 |
_bEndocrine, metabolic & immune disorders drug targets _cDec 2008 |
||
| 300 |
_a255-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAngiogenic Proteins _xphysiology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCD36 Antigens _xdrug effects |
| 650 | 0 | 4 |
_aCornea _xblood supply |
| 650 | 0 | 4 |
_aCorneal Neovascularization _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aRegional Blood Flow _xphysiology |
| 700 | 1 | _aYang, C | |
| 700 | 1 | _aOng, H | |
| 700 | 1 | _aChemtob, S | |
| 700 | 1 | _aHardy, P | |
| 773 | 0 |
_tEndocrine, metabolic & immune disorders drug targets _gvol. 8 _gno. 4 _gp. 255-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/187153008786848330 _zAvailable from publisher's website |
| 999 |
_c18528484 _d18528484 |
||